newsfilter
← Latest News
GlobeNewswire·

Progenity to Become Biora Therapeutics as it Completes Transformation

SAN DIEGO, April 12, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ:PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced that it will change its name to Biora Therapeut